{"id":596543,"date":"2022-04-19T20:52:01","date_gmt":"2022-04-19T20:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=596543"},"modified":"2022-04-19T20:52:01","modified_gmt":"2022-04-19T20:52:01","slug":"ascites-market-to-grow-substantially-during-the-forecast-period-delveinsight-key-companies-biovie-grifols-sa-noorik-biopharmaceuticals-and-clover-biopharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/ascites-market-to-grow-substantially-during-the-forecast-period-delveinsight-key-companies-biovie-grifols-sa-noorik-biopharmaceuticals-and-clover-biopharmaceuticals_596543.html","title":{"rendered":"Ascites Market to Grow Substantially During the Forecast Period – DelveInsight | Key Companies – BioVie, Grifols S.A., Noorik Biopharmaceuticals, and Clover Biopharmaceuticals"},"content":{"rendered":"
\n
\"Ascites<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Ascites Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Ascites Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/div>\n

The Ascites market report<\/strong> covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Ascites<\/p>\n

Ascites: An Overview<\/strong><\/p>\n

Ascites are defined as an accumulation of more than 25 mL of fluid in the peritoneal cavity. Cirrhosis of the liver is the most common cause of ascites, but other conditions such as heart failure, kidney failure, infection, or cancer can also cause the disease. Ascites are caused by a combination of elevated pressure in the veins running through the liver (portal hypertension) and a decrease in liver function caused by scarring of the liver, i.e., cirrhosis.<\/em><\/p>\n

Most patients who develop ascites notice abdominal distension and rapid weight gain. Some people also develop swelling of the ankles and shortness of breath from the accumulation of fluid around the lungs.<\/em><\/p>\n

Ascites related to portal hypertension (cirrhosis, congestive heart failure, Budd-Chiari) is generally greater than 1.1., and ascites caused by other reasons (malignant, pancreatitis) are lower than 1.1.<\/em><\/p>\n

Ascites Market Key Facts<\/strong><\/p>\n